colforsin has been researched along with Multiple Sclerosis in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Alasmari, AF; Alharbi, M; Alshammari, A; Assiri, MA; Kalfin, R; Kapoor, T; Kumar, N; Mehan, S; Narula, AS; Sharma, N; Suri, M | 1 |
Biesta, PJ; Kuipers, HF; Montagne, LJ; van den Elsen, PJ; van der Valk, P; van Haastert, ES | 1 |
Sawada, M; Suzumura, A; Takayanagi, T; Tamaru, T; Yoshikawa, M | 1 |
3 other study(ies) available for colforsin and Multiple Sclerosis
Article | Year |
---|---|
Forskolin, an Adenylcyclase/cAMP/CREB Signaling Activator Restoring Myelin-Associated Oligodendrocyte Destruction in Experimental Ethidium Bromide Model of Multiple Sclerosis.
Topics: Adenylyl Cyclases; Animals; Colforsin; Cytokines; Demyelinating Diseases; Donepezil; Ethidium; Fingolimod Hydrochloride; Gliotoxin; Memantine; Multiple Sclerosis; Myelin Basic Protein; Myelin Sheath; Nerve Growth Factors; Neurodegenerative Diseases; Oligodendroglia; Rats; Rats, Wistar; Simvastatin | 2022 |
CC chemokine receptor 5 gene promoter activation by the cyclic AMP response element binding transcription factor.
Topics: Base Sequence; Binding Sites; Cell Line; Cells, Cultured; Colforsin; Cyclic AMP Response Element-Binding Protein; Dendritic Cells; DNA Primers; Gene Expression Regulation; Humans; Interferon Regulatory Factor-1; Microglia; Monocytes; Multiple Sclerosis; NF-kappa B; Promoter Regions, Genetic; Protein Binding; Receptors, CCR5; RNA, Messenger; T-Lymphocytes; Transcription, Genetic; Transcriptional Activation | 2008 |
Effects of phosphodiesterase inhibitors on cytokine production by microglia.
Topics: 1-Methyl-3-isobutylxanthine; Amrinone; Animals; Anti-Ulcer Agents; Cilostazol; Colforsin; Dipyridamole; DNA Primers; Gene Expression Regulation, Enzymologic; Interleukin-1; Interleukin-6; Mice; Mice, Inbred C57BL; Microglia; Multiple Sclerosis; Papaverine; Pentoxifylline; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Pyrazines; Pyrrolidinones; Quinolines; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; Rolipram; Tetrazoles; Theophylline; Tumor Necrosis Factor-alpha; Vinca Alkaloids; Xanthines | 1999 |